Safety and Efficacy of Dexmedetomidine (DEX) for Sedation of Subjects ≥1 Month to <17 Years Undergoing MRI Scans
Status:
Recruiting
Trial end date:
2021-11-28
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, dose-ranging study of the efficacy and safety of
dexmedetomidine (DEX) when used with propofol as needed, for procedural sedation of pediatric
subjects ≥1 month to <17 years of age undergoing MRI scans in the US and Japan.